Nonconformance & Deviation Review Services for Medical Devices

A deviation is a departure from an approved process, procedure, instruction, or specification during operations. A nonconformance is a failure of a product, material, process, or system to meet defined requirements. In practice, deviations often focus on what went off-procedure, while nonconformances focus on what failed acceptance criteria. Both require documented review, impact assessment, and appropriate disposition.

Organizations commonly group deviations into planned deviations, unplanned deviations, temporary deviations, and recurring or systemic deviations. The exact categories can vary by quality system, but the purpose is the same: classify the event correctly so review depth, approvals, risk assessment, and CAPA escalation are handled consistently. A strong procedure should define each type and the required documentation path.

A deviation should be escalated to CAPA when it indicates a recurring issue, systemic process weakness, ineffective controls, significant product or patient risk, or a trend that cannot be justified as isolated. CAPA is also appropriate when root cause analysis shows broader quality system impact. Proper escalation ensures corrective actions, effectiveness checks, and management visibility are formally documented.

The review should assess affected lots or units, traceability records, acceptance data, complaint history, distribution status, and the nature of the requirement that was not met. Teams also evaluate whether the issue changes safety, performance, labeling, sterility, software behavior, or regulatory commitments. A defensible assessment documents scope, rationale, and any required containment, field action, or reportability decision.

Typical records include the deviation report, batch or device history records, work instructions, SOPs, training records, equipment logs, calibration records, environmental data, supplier records, test results, and prior related events. Depending on the issue, reviewers may also examine CAPAs, complaints, risk management files, DHF records, and change controls. The goal is to establish facts, impact, root cause, and closure rationale.

Yes, but only when the event is minor, clearly understood, low risk, and supported by objective evidence showing no broader product or process impact. Even then, the rationale for limited investigation must be documented and approved under the quality system procedure. If there is uncertainty, recurrence, or possible compliance impact, a deeper investigation and possible CAPA linkage are usually warranted.

Well-run deviation reviews show that the manufacturer identifies quality events promptly, evaluates impact systematically, documents decisions clearly, and escalates issues appropriately. That supports core expectations under FDA quality system requirements and ISO 13485 for control of nonconforming product, corrective action, records, and risk-based decision-making. Inspectors look for consistency, traceability, timeliness, and evidence that issues are not being minimized.

A strong process includes clear event definitions, standardized classification rules, timely containment, documented impact assessment, investigation criteria, disposition pathways, CAPA escalation thresholds, approval requirements, and closure checks. It should also connect to complaints, risk management, change control, and post-market surveillance where relevant. The best systems produce consistent decisions and records that are easy to defend during audits or inspections.